Also known as Pariet and Aciphex
Rabeprazole /ˌræ.ˈbɛp.ræ.zɔːl/ is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names AcipHex (/ˈæsɨfɛks/, referring to pH) in the US, Pariet in Europe, Brazil, Canada, Japan, Russia and Australia, and Razo, Parit and Orpro in India.Source: Wikipedia
Estimated Total Cost: $199.99 for an average of 28 days supply
Patients are most commonly prescribed rabeprazole to treat gastroesophageal reflux disease (gerd), heartburn, hoarse voice, and esophagitis.